INVO Bioscience, Inc. (INVO)
| Market Cap | 41.59M |
| Revenue (ttm) | 1.04M |
| Net Income (ttm) | -8.35M |
| Shares Out | 10.42M |
| EPS (ttm) | -1.52 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 12 |
| Last Price | $3.94 |
| Previous Close | $3.71 |
| Change ($) | 0.23 |
| Change (%) | 6.20% |
| Day's Open | 3.90 |
| Day's Range | 3.85 - 4.08 |
| Day's Volume | 123,529 |
| 52-Week Range | 2.90 - 12.30 |
SARASOTA, Fla., May 11, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcel...
SARASOTA, Fla., May 10, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOcel...
SARASOTA, Fla., April 26, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOc...
SARASOTA, Fla., April 22, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOc...
SARASOTA, Fla. and SAN FRANCISCO, April 19, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture S...
VNET, ALTG, FPI, HALL, and INVO have been added to the Zacks Rank #5 (Strong Sell) List on April 16, 2021
SARASOTA, Fla., April 12, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and devel...
SARASOTA, Fla., March 30, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and devel...
SARASOTA, Fla., March 29, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOc...
SARASOTA, Fla., March 26, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOc...
SARASOTA, Fla. and BIRMINGHAM, Ala.
SARASOTA, Fla., March 11, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOc...
Shares of INVO Bioscience, Inc. (NASDAQ: INVO) gained more than 202% in the regular trading session on Tuesday. What Happened: The sharp gains came after the Sarasota, Massachusetts-based medical device...
INVO stock is on the move Tuesday after INVO Bioscience announced plans to expand its fertility clinic footprint. The post INVO Stock: Why INVO Bioscience Is Skyrocketing Today appeared first on Investo...
Invo Bioscience Inc (NASDAQ: INVO) shares have gained sharply after an amendment under its exclusive U.S. commercialization agreement with Ferring Pharmaceuticals. The amendment provides an increase in ...
SARASOTA, Fla., March 8, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOce...
SARASOTA, Fla., March 1, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOce...
SARASOTA, Fla., Jan. 15, 2021 /PRNewswire/ -- INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world's only in vivo Intravaginal Culture System (IVC), INVOce...
About INVO
INVO Bioscience, Inc., a medical device company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a patented intravaginal culture system used for the natural in vivo incubation of eggs and sperm during fertilization and early embryo development. The company was founded in 2007 and is based in Sarasota, Massachusetts.
| Industry Medical Devices | Founded 2007 |
| Stock Exchange NASDAQ | Ticker Symbol INVO |
Financial Performance
In 2020, INVO's revenue was $1.04 million, a decrease of -29.92% compared to the previous year's $1.48 million. Losses were -$8.35 million, 285.1% more than in 2019.
Analyst Forecasts
According to 2 analysts, the average rating for INVO stock is "Buy." The 12-month stock price forecast is 5.88, which is an increase of 49.24% from the latest price.